Cyanocobalamin is a form of vitamin B12 often used to treat vitamin B12 deficiency, common in people with diabetes.
Combining tirzepatide and cyanocobalamin will benefit people with type 2 diabetes. Cyanocobalamin may help to address the risk of vitamin B12 deficiency that is associated with diabetes, while tirzepatide helps to lower blood sugar levels.
Studies have shown that tirzepatide can significantly improve glycemic control in people with type 2 diabetes, reducing HbA1c levels (a measure of blood sugar control over time). Cyanocobalamin can also help to improve glycemic control and has been shown to have additional benefits, such as reducing inflammation and improving nerve function.
Some evidence suggests that vitamin B12 supplementation may have a modest effect on weight loss. Vitamin B12 is involved in the metabolism of fats and carbohydrates, and a deficiency in this vitamin may lead to a slower metabolism and reduced energy levels.
Additionally, tirzepatide has been shown to lead to significant weight loss in clinical trials, with some patients losing up to 15% of their body weight. It works by reducing appetite and increasing feelings of fullness, which can help to reduce calorie intake and promote weight loss.
The use of this medication in studies resulted in the following :
- Substantial A1C reductions.
- Improvements in cardiometabolic measures.